Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance CBT and Paroxetine for Panic Disorder
NCT00000368Phase 3Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Feb 1999
- Primary completion
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of paroxetine in panic disorder (4 arms), sponsored by New York State Psychiatric Institute. Primary endpoints: Panic Disorder Severity Scale and Clinical Global Impressions. Started Feb 1999; status: completed.
02
Drugs
paroxetine
03
Conditions
panic disorder
Beyond the preview
Go deeper on NCT00000368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000368.